Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor Modulators
AssigneeJanssen Pharmaceutica NV
InventorsWenying Chai, Michael A. Letavic, Kiev S. Ly, Daniel J. Pippel, Dale A. Rudolph, Kathleen C. Sappey, Brad M. Savall, Chandravadan R. Shah, Brock T. Shireman, Akinola Soyode Johnson, Emily M. Stocking, Devin M. Swanson
Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
Drawings
Claims21
A chemical entity that is a compound of Formula (I):
wherein:
R1 is phenyl substituted or unsubstituted with one Ra and Rb in the ortho position;
Ra is halo, C1-4alkyl, or C1-4alkoxy;
Rb is triazole or pyrimidine substituted or unsubstituted with halo or C1-4alkyl;
R2 is a 6-membered heteroaryl ring containing two nitrogen members substituted with one or more member selected from the group consisting of halo, C1-4alkyl, CD3, D, C1-4alkoxy, cyclopropyl, morpholin-2-yl, CO2C1-4alkyl, CO2H, CH2OH, C(O)N(C1-4alkyl)2, CF3, CN, OH, NO2, N(C1-4alkyl)2, phenyl, furan-2-yl, thiophen-2-yl, 1H-pyrazol-4-yl, and pyrrolidin-1-yl;
or a pharmaceutically acceptable salt of a compound of Formula (I).
3 more elements
A pharmaceutical composition for treating a disease, disorder or medical condition mediated by orexin activity comprising:
(a) an effective amount of at least one chemical entity of Formula (I):
wherein:
R1 is phenyl substituted or unsubstituted with one Ra and Rb in the ortho position;
Ra is halo, C1-4alkyl, or C1-4alkoxy;
Rb is triazole or pyrimidine substituted or unsubstituted with halo or C1-4alkyl;
R2 is a 6-membered heteroaryl ring containing two nitrogen members substituted with one or more member selected from the group consisting of halo, C1-4alkyl, CD3, D, C1-4alkoxy, cyclopropyl, morpholin-2-yl, CO2C1-4alkyl, CO2H, CH2OH, C(O)N(C1-4alkyl)2, CF3, CN, OH, NO2, N(C1-4alkyl)2, phenyl, furan-2-yl, thiophen-2-yl, 1H-pyrazol-4-yl, and pyrrolidin-1-yl;
or a pharmaceutically acceptable salt of a compound of Formula (I);
and
(b) at least one pharmaceutically acceptable excipient.
6 more elements
A method of treating a disease, disorder or medical condition mediated by orexin activity that is a sleep-wake transition disorder, insomnia, restless legs syndrome, jet-lag, disturbed sleep, or a sleep disorder secondary to neurological disorders, comprising administering to a patient in need thereof at least one chemical entity of a compound of Formula (I):
wherein:
R1 is phenyl substituted or unsubstituted with one Ra and Rb in the ortho position;
Ra is halo, C1-4alkyl, or C1-4alkoxy;
Rb is triazole or pyrimidine substituted or unsubstituted with halo or C1-4alkyl;
R2 is a 6-membered heteroaryl ring containing two nitrogen members substituted with one or more member selected from the group consisting of halo, C1-4alkyl, CD3, D, C1-4alkoxy, cyclopropyl, morpholin-2-yl, CO2C1-4alkyl, CO2H, CH2OH, C(O)N(C1-4alkyl)2, CF3, CN, OH, NO2, N(C1-4alkyl)2, phenyl, furan-2-yl, thiophen-2-yl, 1H-pyrazol-4-yl, and pyrrolidin-1-yl;
or a pharmaceutically acceptable salt of a compound of Formula (I), and at least one pharmaceutically acceptable excipient.
Quinolines; Isoquinolines: non-condensed quinolines and containing further heterocyclic rings
Life of this patent
Term end not estimated
Priority claimedParent application 61/254,509
Application filedUS 16/601,832
Published
Description54,037 words
Summary2,960 words
#The present invention relates to certain disubstituted octahydropyrrolo[3,4-c]pyrrole compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them for the modulation of the orexin receptor and for the treatment of disease states, disorders, and conditions mediated by orexin receptor activity.
#Orexin (or hypocretin) signaling is mediated by two receptors and two peptide agonists. The two orexin peptides (orexin A and orexin B) herein after referred to as orexins, bind to two high affinity receptors, termed orexin-1 and orexin-2 receptors. The orexin-1 receptor is selective in favor of orexin A, while the orexin-2 receptor binds both orexins with similar affinities. The orexins are cleavage products of the same gene, prepro orexin. In the central nervous system neurons expressing prepro-orexin, the precursor from which orexin is produced, are found in the perifornical nucleus, the dorsal hypothalamus and the lateral hypothalamus (C. Peyron et al., J. Neurosci., 1998, 18(23), 9996-10015). Orexinergic cells in these nuclei project to many areas of the brain, extending rostrally to the olfactory bulbs and caudally to the spinal cord (van den Pol, A. N. et al., J. Neuroscience., 1999, 19(8), 3171-3182).
#The broad CNS distribution of orexin projections and neurons expressing orexin receptors is suggestive of orexin involvement in a number of physiological functions including; feeding, drinking, arousal, stress, reward, metabolism and reproduction (T. Sakurai, Nature Reviews Neuroscience, 2007, 8(3), 171-181).
Brief description of the drawings1 figure
#FIG. 1 is a Powder X-Ray Diffraction of an exemplified compound X
Detailed description51,065 words
#The invention may be more fully appreciated by reference to the following description, including the following glossary of terms and the concluding examples. For the sake of brevity, the disclosures of the publications, including patents, cited in this specification are herein incorporated by reference.
#As used herein, the terms “including”, “containing” and “comprising” are used herein in their open, non-limiting sense.
#The term “alkyl” refers to a straight- or branched-chain alkyl group having from 1 to 12 carbon atoms in the chain. Examples of alkyl groups include methyl (Me, which also may be structurally depicted by the symbol, “/”), ethyl (Et), n-propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl (tBu), pentyl, isopentyl, tert-pentyl, hexyl, isohexyl, and groups that in light of the ordinary skill in the art and the teachings provided herein would be considered equivalent to any one of the foregoing examples.